HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- ECNU's intl student program benefits mother and daughter from Vietnam
- Digital creativity shines at intl copyright expo in Qingdao
- China's rocket launches Pakistan remote-sensing satellite into orbit
- Legal scholars affirm Taiwan resolution at UN seminar in Wuhan
- Shanghai demonstrates ecological protection, building a green future
- Lithium battery spontaneously combusts on flight from Hangzhou in China to Seoul, no injuries reported